General Information
Version
5.0
Revision date
2023-08-17
Product name
KNOCKOUT PATHWAY & PATIO CLEANER
1.2.2. Uses advised against
Any other use not identified
Manufacturer Name
J.V. Barrett & Co. Ltd Ltd
Emergency telephone
+44 (0) 1179 600060, +44 (0) 1270 502891, 0344 892 0111, 0845 4647
Icons in SDS
Company Information
company name
J.V. Barrett & Co. Ltd Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sales@barrettine.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H290, H315, H319
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May be corrosive to metals. Harmful if inhaled. Harmful if swallowed. Causes severe skin burns and eye damage. Causes serious eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H290 - May be corrosive to metals. H315 - Causes skin irritation. H319 - Causes serious eye irritation.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P234 - Keep only in original packaging. P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Child-resistant fastening : Not applicable Tactile warning : Not applicable
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %